Riverview Capital Advisers, LLC
Position in CLRB — Cellectar Biosciences, Inc.
CIK 1962933
BOSTON, MA
Position in CLRB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$28,867
+$2,492 QoQ
Shares Held
10,384
0.0% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 29 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CLRB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Riverview Capital Advisers, LLC holds $90,034 across 2 Biotechnology names. CLRB ranks #2 (32.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMNN |
Imunon, Inc.
|
34,364 | $61,167 | |
| 2 | CLRB |
Cellectar Biosciences, Inc.
This page
|
10,384 | $28,867 |
All Filings in CLRB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,867 | 10,384 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $26,375 | 10,384 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $30,632 | 10,384 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $58,150 | 10,384 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $74,655 | 10,500 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||